Peripheral neuropathies under Immune Checkpoint Inhibitors: A pharmacovigilance study

被引:0
|
作者
Ewig, E. [1 ]
Fournier, D. [1 ]
Palassin, P. [2 ]
Cholle, C. [3 ]
Bihan, B. [1 ]
Lebrun-Vignes, B. [1 ]
机构
[1] GH Sorbonne Univ, Dept Pharmacol, Ctr Reg Pharmacovigilance Pitie St Antoine, AP HP, Paris, France
[2] CHU Montpellier, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale & Toxicol, Montpellier, France
[3] CHU Bordeaux, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale, Pole Sante Publ, Bordeaux, France
关键词
immune checkpoint inhibitors; peripheral neuropathy; pharmacovigilance;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS-043
引用
收藏
页码:117 / 118
页数:2
相关论文
共 50 条
  • [41] Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
    Mo, Diwei
    Yang, Xia
    Xu, Guifeng
    Zhang, Xiaoyue
    Wang, Keng
    Lei, Luwen
    Pan, Xingxi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] IMMUNE CHECKPOINT INHIBITORS RELATED PERIPHERAL NERVE DISORDERS: CLINICAL AND ELECTROPHYSIOLOGICAL PARTICULARITIES
    Cristina, Birzu
    Devic, Perrine
    Farina, Antonio
    Magot, Armelle
    Bihan, Kevin
    Bourdain, Frederick
    Pegat, Antoine
    Lenglet, Timothee
    Fargeot, Guillaume
    Debs, Rabab
    Viala, Karine
    Picca, Alberto
    Mongin, Marie
    Villette, Beatrice
    Alberto, Tiffanie
    Lemarchant, Bruno
    Gendre, Thierry
    Tafani, Camille
    Joubert, Bastien
    Maisonobe, Thierry
    Psimaras, Dimitri
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S117 - S117
  • [43] Immune checkpoint inhibitors in GBM
    Lee, Eudocia Q.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (01) : 1 - 11
  • [44] Immune Checkpoint Inhibitors in NSCLC
    Johnson, Douglas B.
    Rioth, Matthew J.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 658 - 669
  • [45] Cardiotoxicity of Immune Checkpoint Inhibitors
    Patel, Rushin P.
    Parikh, Rohan
    Gunturu, Krishna S.
    Tariq, Rana Zouveenoor
    Dani, Sourbha S.
    Ganatra, Sarju
    Nohria, Anju
    CURRENT ONCOLOGY REPORTS, 2021, 23 (07)
  • [46] Immune Checkpoint Inhibitors in Gliomas
    Aaron C. Tan
    Amy B. Heimberger
    Mustafa Khasraw
    Current Oncology Reports, 2017, 19
  • [47] Cardiotoxicity of Immune Checkpoint Inhibitors
    Rushin P. Patel
    Rohan Parikh
    Krishna S. Gunturu
    Rana Zouveenoor Tariq
    Sourbha S. Dani
    Sarju Ganatra
    Anju Nohria
    Current Oncology Reports, 2021, 23
  • [48] Melanoma and Immune Checkpoint Inhibitors
    Masutaka Furue
    Takamichi Ito
    Naoko Wada
    Maiko Wada
    Takafumi Kadono
    Hiroshi Uchi
    Current Oncology Reports, 2018, 20
  • [49] Cardiotoxicity of Immune Checkpoint Inhibitors
    Zhang L.
    Jones-O’Connor M.
    Awadalla M.
    Zlotoff D.A.
    Thavendiranathan P.
    Groarke J.D.
    Villani A.-C.
    Lyon A.R.
    Neilan T.G.
    Current Treatment Options in Cardiovascular Medicine, 2019, 21 (7)
  • [50] Immune Checkpoint Inhibitors in NSCLC
    Douglas B. Johnson
    Matthew J. Rioth
    Leora Horn
    Current Treatment Options in Oncology, 2014, 15 : 658 - 669